Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003056613 | SCV003446432 | pathogenic | Holocarboxylase synthetase deficiency | 2023-09-13 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 2140758). This variant has not been reported in the literature in individuals affected with HLCS-related conditions. This variant is present in population databases (rs751956557, gnomAD 0.004%). This sequence change creates a premature translational stop signal (p.His406Argfs*15) in the HLCS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HLCS are known to be pathogenic (PMID: 16134170). |
Baylor Genetics | RCV003056613 | SCV004199849 | likely pathogenic | Holocarboxylase synthetase deficiency | 2024-02-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV004725494 | SCV005332467 | likely pathogenic | not provided | 2024-02-12 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge |